Format

Send to

Choose Destination
See comment in PubMed Commons below
J Natl Cancer Inst. 2014 Feb;106(2):djt454. doi: 10.1093/jnci/djt454.

ALK1 as a novel therapeutic target for CD30⁺ T-anaplastic large cell lymphoma.

Author information

  • 1Affiliation of authors: Division of Hematology/Oncology, University of Florida, Gainesville, FL (JWH, NHD).
PMID:
24491304
DOI:
10.1093/jnci/djt454
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center